Detection of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae producing NDM-1 in Lebanon

Journal of Infection in Developing Countries

Volumn 6, Issue 5, 2012, Pages 457-461

  El Herte, Rima I ^a   Araj, George F ^a   Matar, Ghassan M ^a   Baroud, Maysa ^a   Kanafani, Zeina A ^a   Kanj, Souha S ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Carbapenem; Carbapenemases; Enterobacteriaceae; Lebanon; New Delhi metallo beta lactamase; Resistant

Indexed keywords

AMINOGLYCOSIDE; AZTREONAM; CARBAPENEM; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; COLISTIN; DORIPENEM; ERTAPENEM; FOSFOMYCIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; NEW DELHI METALLO BETA LACTAMASE 1; OUTER MEMBRANE PROTEIN C; OUTER MEMBRANE PROTEIN F; QUINOLONE DERIVATIVE; TIGECYCLINE; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENE; HUMAN; KLEBSIELLA PNEUMONIAE; LEBANON;

ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE;

EID: 84861377869     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.2340     Document Type: Article

References (25)

1. Livermore DM (2009) Has the era of untreatable infections arrived? J Antimicrob Chemother 64 Supp 1: i29-i36.
2. Matar GM, Cuzon G, Araj GF, Naas T, Corkill J, Kattar MM, Nordmann P (2008) Oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Lebanon. Clin Microbiol Infect 14: 887-888.
3. Matar GM, Dandache I, Carraer A, Khairallah MT, Nordmann P, Sabra A, Araj GF (2010) Spread of OXA-48-mediated resistance to carbapenems in Lebanese Klebsiella pneumoniae and Escherichia coli that produce extended spectrum β-lactamase. Ann Trop Med Parasitol 104:271-274.
4. Clinical and Laboratory Standards Institute (2010) Performance standards for antimicrobial susceptibility testing; 20th informational supplement. Approved standard, CLSI document M100-S19. Wayne, PA.
5. Poirel L, Heritier C, Toluen V, Nordmann P (2004) Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumonia. Antimicrob Agents Chemother 48: 15-22.
6. Gacar GG, Midilli K, Kolayli F, Ergen K, Gundes S, Hosoglu S, Karadenizli A, Vahaboglu H (2005) Genetic and Enzymatic Properties of metallo-β-lactamase VIM-5 from a clinical isolate of Enterobacter cloacae. Antimicrob Agents Chemother 49: 4400-4403.
7. Carrer A, Poirel L, Yilmaz M, Akan OA, Feriha C, Cuzon G, Matar G, Honderlick P, Nordmann P (2010) Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrob Agents Chemother 54: 1369-1373.
8. Ikonomidis A, Labrou M, Afkou Z, Maniatis AN, Sofianou D, Tsakris A, Pournaras S (2007) First Occurrence of an Escherichia coli clinical isolate producing the VIM-1/VIM-2 hybrid metallo-β-lactamase VIM-12. Antimicrob Agents Chemother 51: 3038-3039.
9. Giakkoupi P, Pappa O, Polemis M, Vatopoulos AC, Miriagou V, Zioga A, Papagiannitsis CC, Tzouvelekis LS (2009) Emerging Klebsiella pneumoniae isolates coproducing KPC-2 and VIM-1 Carbapenemases. Antimicrob Agents Chemother 53: 4048-4050.
10. Pournaras S, Poulou A, Voulgari E, Vrioni G, Kristo I, Tsakris A (2010) Detection of the new metallo-b-lactamase VIM-19 along with KPC-2, CMY-2 and CTX-M-15 in Klebsiella pneumonia. J Antimicrob Chemother 65:1604-1607.
11. Cuzon G, Naas T, Carrer A, Honderlick P, Cerf C, Nordmann P (2009) Plasmid-Mediated Carbapenem-Hydrolyzing ß-Lactamase OXA-48 in Klebsiella pneumoniae from Egypt. Abstract Number C2-649 at the 49th ICAAC, Sept 12-15, San Francisco, Calif, USA.
12. Guerin F, Henegar C, Spiridon G, Launay O, Salmon-Ceron D, Poyart C (2005) Bacterial prostatitis due to Pseudomonas aeruginosa harbouring the blaVIM-2 metallo-β-lactamase gene from Saudi Arabia. J Antimicrob Chemother 56: 601-602.
13. Poirel L, Al Maskari Z, Al Rashdi F, Bernabeu S, Nordmann P (2011) NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman. J Antimicrob Chemother 66: 304-306.
14. Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y (2007) Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae Strains in an Israeli Hospital. Antimicrob Agents Chemother 51: 3026-3029.
15. Poirel L, Fortineau N, Nordmann P (2011) International transfer of NDM-1-producing Klebsiella pneumoniae from Iraq to France. Antimicrob Agents Chemother 55: 1821-1822.
16. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt FA, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, Krishnan P, Kumar AV, Maharjan S, Mushtaq S, Noorie T, Paterson DL, Pearson A, Perry C, Pike R, Rao B, Ray U, Sarma JB, Sharma M, Sheridan E, Thirunarayan MA, Turton J, Upadhyay S, Warner M, Welfare W, Livermore DM, Woodford N (2010) Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10:597-602.
17. Health Protection Agency (2009) Multi-resistant hospital bacteria linked to India and Pakistan: Health Protection Report 2009. 3: 3-4. http://www.hpa.org.uk/hpr/archives/2009/hpr2609.pdf. Last accessed 27 April 2012.
18. El-Herte RI, Kanj SS, Matar GM, Araj GF (2012) The threat of carbapenem-resistant Enterobac-teriaceae in Lebanon: An update on the regional and local epidemiology. J Infect Public Health. doi:10.1016/j.jiph.2012.02.003
19. Lopez JA, Correa A, Navon-Venezia S, Correa LA, Torres A, Briceno DF, Montealegre MC, Quinn JP, Carmeli Y, Villegas MV (2011) Intercontinental spread from Israel to Colombia of a KPC-3-producing Klebsiella pneumoniae strain. Clin Microbiol Infect 17: 52-55.
20. Bratu S, Tolaney P, Karumudi U, Quale J, Mooty M, Nichani S, Landman D (2005) Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother 56: 128-132.
21. Samra Z, Ofira O, Lishtzinsky Y, Madar-Shapiro L, Bishara J (2007) Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. Int J Antimicrob Agents 30: 525-529.
22. Anthony KB, Fishman NO, Linkin DR, Gasink LB, Edelstein PH, Lautenbach E (2008) Clinical and microbiological outcomes of serious infections with multidrug-resistant Gram-negative organisms treated with tigecycline. Clin Infect Dis 46: 567-570.
23. Hirsch EB and Tam VH (2010) Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother 65: 1119-1125.
24. Castanheira M, Sader HS, Deshpande LM, Fritsche TR, Jones RN (2008) Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase-and metallo-β-lactamase-producing enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother 52: 570-573.
25. Endimiani A, Patel G, Hujer KM, Swaminathan M, Perez F, Rice LB, Jacobs MR, Bonomo RA (2010) In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or olisctin. Antimicrob Agents Chemother 54: 526-529.